On November 7, 2023 Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, reported that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to present at the following investor conferences (Press release, Geron, NOV 7, 2023, View Source [SID1234637138]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Stifel 2023 Healthcare Conference
Tuesday, November 14th at 9:10 a.m. ET (Fireside Chat)

Piper Sandler 35th Annual Healthcare Conference
Tuesday, November 28th at 9:30 a.m. ET (Corporate Presentation)

6th Annual Evercore ISI HealthCONx Conference
Wednesday, November 29th at 10:50 a.m. ET (Fireside Chat)

A webcast of each fireside chat and corporate presentation will be available through the Investor Relations section of the Company’s website under Events. An archive of the webcast will be available on the Company’s website for 30 days.